drugset / Trial / NCT00488215
A Trial in Healthy Volunteers, to Evaluate the Tolerability and Cardiac Safety of Prucalopride
RandomizedCrossoverDouble-blind
Summary
An escalating dose of prucalopride up to a maximum of 20 mg was given once daily to 32 healthy volunteers to determine safety at the maximum tolerable dose or at 20 mg.
Timeline
- Start
- 2000-01
- Primary completion
- 2000-03
- Completion
- 2000-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prucalopride | Small molecule | 20 mg | Oral |